Share Price and Basic Stock Data
Last Updated: November 14, 2025, 11:29 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Caprihans India Ltd operates in the plastics sector, specifically focusing on pipes and fittings. The company’s revenue for FY 2025 stood at ₹752 Cr, reflecting a decline from ₹937 Cr in FY 2023 but an increase from ₹704 Cr in FY 2024. This fluctuation in sales indicates a challenging market environment, with sales for the quarter ending March 2025 reported at ₹186.40 Cr, compared to ₹226.44 Cr in the previous year. The latest quarterly sales figures suggest a continuing struggle with maintaining revenue momentum, especially as the June 2024 sales decreased to ₹182.35 Cr from ₹190.98 Cr in March 2024. Despite these challenges, Caprihans remains a player in the industry, with a market capitalization of ₹166 Cr, indicating a relatively small yet significant presence in the market landscape.
Profitability and Efficiency Metrics
Caprihans reported a net profit of ₹2.70 Cr for FY 2025, a notable turnaround from the previous year’s losses, which included a net loss of ₹62 Cr in FY 2025. However, the company’s operating profit margin (OPM) stood at a modest 3.59%, reflecting ongoing operational challenges. The company’s interest coverage ratio (ICR) was recorded at a low 0.63x, indicating potential difficulties in meeting interest obligations. The return on equity (ROE) was reported at 18.9%, which is relatively strong compared to industry averages, but the return on capital employed (ROCE) was significantly low at 0.78%, suggesting inefficiencies in capital utilization. Additionally, the cash conversion cycle (CCC) of 82 days reflects a longer-than-average period for converting investments into cash, which could impact liquidity and operational agility.
Balance Sheet Strength and Financial Ratios
Caprihans’ balance sheet shows a total debt of ₹841 Cr against reserves of ₹272 Cr, resulting in a debt-to-equity ratio of 1.58, highlighting a leveraged position. The current ratio is reported at 0.78, indicating liquidity concerns as it falls below the ideal threshold of 1, suggesting potential difficulties in meeting short-term liabilities. The book value per share stood at ₹295.46, while the price-to-book value ratio (P/BV) was notably low at 0.43x, indicating that the stock may be undervalued relative to its net assets. The company’s working capital days for FY 2025 were reported at -37, which signals a tight operating cycle, potentially affecting operational flexibility. Overall, the financial ratios indicate a company that, while facing challenges, possesses assets that could be leveraged for future growth.
Shareholding Pattern and Investor Confidence
As of March 2025, Caprihans had a promoter holding of 54.75%, which suggests a strong commitment from the founding shareholders. The public shareholding stood at 45.22%, with negligible foreign institutional investment (FIIs) and domestic institutional investment (DIIs) at 0.01%. This distribution indicates a predominantly retail investor base, which can reflect either confidence or caution among institutional investors. The number of shareholders has fluctuated slightly, with 7,365 shareholders reported in March 2025, down from 7,421 in the previous quarter. The low institutional participation might signal a lack of confidence in the company’s immediate prospects, particularly given the recent financial performance marked by net losses in several quarters. Investor confidence may hinge on the company’s ability to stabilize its profitability and improve operational efficiency.
Outlook, Risks, and Final Insight
Looking ahead, Caprihans faces both potential for recovery and significant risks. The recent improvement in net profit to ₹2.70 Cr offers a glimmer of hope, but persistent operational inefficiencies and high leverage remain critical concerns. The company must address its low ROCE and OPM to enhance profitability and shareholder value. Risks include the ongoing volatility in sales, which could further strain financial resources, and the high debt levels that may limit strategic flexibility. In a favorable scenario, if Caprihans successfully implements efficiency measures and capitalizes on market opportunities, it could see a sustained recovery. Conversely, continued operational challenges may hinder growth prospects, requiring careful management of resources and strategic planning to navigate the competitive landscape effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Caprihans India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dutron Polymers Ltd | 66.4 Cr. | 111 | 198/107 | 31.6 | 49.1 | 1.35 % | 12.3 % | 9.68 % | 10.0 |
| Captain Polyplast Ltd | 440 Cr. | 73.4 | 128/58.4 | 22.2 | 28.0 | 0.00 % | 16.1 % | 15.0 % | 2.00 |
| Captain Pipes Ltd | 194 Cr. | 12.6 | 21.0/11.7 | 54.4 | 2.69 | 0.00 % | 17.0 % | 13.5 % | 1.00 |
| Caprihans India Ltd | 158 Cr. | 108 | 184/105 | 269 | 0.00 % | 0.78 % | 18.9 % | 10.0 | |
| Ashish Polyplast Ltd | 12.5 Cr. | 36.6 | 63.9/30.0 | 20.7 | 0.00 % | 5.09 % | 2.58 % | 10.0 | |
| Industry Average | 6,014.00 Cr | 219.47 | 51.35 | 86.20 | 0.22% | 10.40% | 10.62% | 8.00 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 240.24 | 239.29 | 239.63 | 231.07 | 226.44 | 171.09 | 178.72 | 163.33 | 190.98 | 182.35 | 191.74 | 191.03 | 186.40 |
| Expenses | 223.25 | 224.24 | 226.06 | 219.89 | 206.09 | 157.43 | 160.77 | 146.05 | 195.91 | 166.92 | 185.27 | 183.32 | 179.71 |
| Operating Profit | 16.99 | 15.05 | 13.57 | 11.18 | 20.35 | 13.66 | 17.95 | 17.28 | -4.93 | 15.43 | 6.47 | 7.71 | 6.69 |
| OPM % | 7.07% | 6.29% | 5.66% | 4.84% | 8.99% | 7.98% | 10.04% | 10.58% | -2.58% | 8.46% | 3.37% | 4.04% | 3.59% |
| Other Income | 3.07 | 4.70 | 12.60 | -2.83 | 123.54 | 4.86 | 2.75 | 3.73 | 5.06 | 3.82 | -6.02 | -6.41 | 18.62 |
| Interest | 17.11 | 15.73 | 16.34 | 16.31 | 11.15 | 19.51 | 20.32 | 21.07 | 21.81 | 20.97 | 21.43 | 20.14 | 19.07 |
| Depreciation | 8.51 | 8.49 | 8.50 | 8.68 | 7.62 | 10.07 | 10.05 | 10.05 | 12.81 | 10.80 | 10.35 | 11.02 | 10.82 |
| Profit before tax | -5.56 | -4.47 | 1.33 | -16.64 | 125.12 | -11.06 | -9.67 | -10.11 | -34.49 | -12.52 | -31.33 | -29.86 | -4.58 |
| Tax % | 33.63% | 12.53% | 182.71% | -1.80% | 24.67% | -3.53% | -2.90% | 34.92% | -48.07% | 40.65% | -9.48% | -38.01% | -158.95% |
| Net Profit | -7.43 | -5.03 | -1.10 | -16.34 | 94.25 | -10.67 | -9.39 | -13.64 | -17.91 | -17.61 | -28.36 | -18.51 | 2.70 |
| EPS in Rs | -5.66 | -3.83 | -0.84 | -12.44 | 71.76 | -8.12 | -7.15 | -10.39 | -13.64 | -13.41 | -21.59 | -14.09 | 1.85 |
Last Updated: May 31, 2025, 6:36 am
Below is a detailed analysis of the quarterly data for Caprihans India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 186.40 Cr.. The value appears to be declining and may need further review. It has decreased from 191.03 Cr. (Dec 2024) to 186.40 Cr., marking a decrease of 4.63 Cr..
- For Expenses, as of Mar 2025, the value is 179.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 183.32 Cr. (Dec 2024) to 179.71 Cr., marking a decrease of 3.61 Cr..
- For Operating Profit, as of Mar 2025, the value is 6.69 Cr.. The value appears to be declining and may need further review. It has decreased from 7.71 Cr. (Dec 2024) to 6.69 Cr., marking a decrease of 1.02 Cr..
- For OPM %, as of Mar 2025, the value is 3.59%. The value appears to be declining and may need further review. It has decreased from 4.04% (Dec 2024) to 3.59%, marking a decrease of 0.45%.
- For Other Income, as of Mar 2025, the value is 18.62 Cr.. The value appears strong and on an upward trend. It has increased from -6.41 Cr. (Dec 2024) to 18.62 Cr., marking an increase of 25.03 Cr..
- For Interest, as of Mar 2025, the value is 19.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 20.14 Cr. (Dec 2024) to 19.07 Cr., marking a decrease of 1.07 Cr..
- For Depreciation, as of Mar 2025, the value is 10.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.02 Cr. (Dec 2024) to 10.82 Cr., marking a decrease of 0.20 Cr..
- For Profit before tax, as of Mar 2025, the value is -4.58 Cr.. The value appears strong and on an upward trend. It has increased from -29.86 Cr. (Dec 2024) to -4.58 Cr., marking an increase of 25.28 Cr..
- For Tax %, as of Mar 2025, the value is -158.95%. The value appears to be improving (decreasing) as expected. It has decreased from -38.01% (Dec 2024) to -158.95%, marking a decrease of 120.94%.
- For Net Profit, as of Mar 2025, the value is 2.70 Cr.. The value appears strong and on an upward trend. It has increased from -18.51 Cr. (Dec 2024) to 2.70 Cr., marking an increase of 21.21 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.85. The value appears strong and on an upward trend. It has increased from -14.09 (Dec 2024) to 1.85, marking an increase of 15.94.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:42 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 242 | 253 | 239 | 233 | 249 | 269 | 289 | 297 | 798 | 937 | 704 | 752 | 751 |
| Expenses | 234 | 242 | 222 | 220 | 242 | 264 | 278 | 274 | 740 | 876 | 660 | 715 | 721 |
| Operating Profit | 8 | 11 | 17 | 13 | 6 | 5 | 12 | 23 | 58 | 60 | 44 | 36 | 30 |
| OPM % | 3% | 4% | 7% | 5% | 3% | 2% | 4% | 8% | 7% | 6% | 6% | 5% | 4% |
| Other Income | 3 | 3 | -2 | 6 | 3 | 4 | 5 | 8 | 11 | 138 | 16 | 10 | 9 |
| Interest | -0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 69 | 60 | 83 | 82 | 80 |
| Depreciation | 4 | 3 | 4 | 3 | 3 | 3 | 4 | 4 | 34 | 33 | 43 | 43 | 43 |
| Profit before tax | 8 | 11 | 11 | 15 | 6 | 5 | 12 | 26 | -34 | 105 | -65 | -78 | -83 |
| Tax % | 35% | 35% | 49% | 34% | 29% | 21% | 23% | 22% | 17% | 32% | -21% | -21% | |
| Net Profit | 5 | 7 | 5 | 10 | 4 | 4 | 9 | 20 | -40 | 72 | -52 | -62 | -58 |
| EPS in Rs | 4.00 | 5.37 | 4.15 | 7.35 | 3.15 | 2.79 | 7.00 | 15.40 | -30.13 | 54.64 | -39.30 | -42.26 | -43.10 |
| Dividend Payout % | 38% | 28% | 36% | 20% | 48% | 27% | -0% | -0% | -0% | -0% | -0% | -0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 40.00% | -28.57% | 100.00% | -60.00% | 0.00% | 125.00% | 122.22% | -300.00% | 280.00% | -172.22% | -19.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | -68.57% | 128.57% | -160.00% | 60.00% | 125.00% | -2.78% | -422.22% | 580.00% | -452.22% | 152.99% |
Caprihans India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 21% |
| 3 Years: | -2% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -16% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 17% |
| 3 Years: | -5% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -18% |
| Last Year: | -15% |
Last Updated: September 5, 2025, 2:51 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 87 | 88 | 80 | 82 | 93 | 100 | 87 | 94 | 94 | 71 | 80 | 56 |
| Inventory Days | 78 | 57 | 88 | 86 | 82 | 71 | 103 | 103 | 87 | 44 | 81 | 82 |
| Days Payable | 38 | 60 | 84 | 51 | 60 | 51 | 70 | 62 | 94 | 73 | 70 | 57 |
| Cash Conversion Cycle | 126 | 84 | 85 | 117 | 116 | 119 | 120 | 135 | 86 | 42 | 91 | 82 |
| Working Capital Days | 103 | 88 | 84 | 113 | 111 | 113 | 107 | 116 | -116 | -8 | -16 | -37 |
| ROCE % | 8% | 10% | 16% | 11% | 5% | 4% | 8% | 18% | 13% | 5% | 2% | 1% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | -46.26 |
| Diluted EPS (Rs.) | -46.26 |
| Cash EPS (Rs.) | -13.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 295.46 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 295.46 |
| Revenue From Operations / Share (Rs.) | 514.03 |
| PBDIT / Share (Rs.) | 35.54 |
| PBIT / Share (Rs.) | 6.13 |
| PBT / Share (Rs.) | -53.82 |
| Net Profit / Share (Rs.) | -42.53 |
| NP After MI And SOA / Share (Rs.) | -42.53 |
| PBDIT Margin (%) | 6.91 |
| PBIT Margin (%) | 1.19 |
| PBT Margin (%) | -10.47 |
| Net Profit Margin (%) | -8.27 |
| NP After MI And SOA Margin (%) | -8.27 |
| Return on Networth / Equity (%) | -14.39 |
| Return on Capital Employeed (%) | 0.96 |
| Return On Assets (%) | -4.95 |
| Long Term Debt / Equity (X) | 1.08 |
| Total Debt / Equity (X) | 1.58 |
| Current Ratio (X) | 0.78 |
| Quick Ratio (X) | 0.42 |
| Interest Coverage Ratio (X) | 0.63 |
| Interest Coverage Ratio (Post Tax) (X) | 0.31 |
| Enterprise Value (Cr.) | 848.61 |
| EV / Net Operating Revenue (X) | 1.15 |
| EV / EBITDA (X) | 16.70 |
| MarketCap / Net Operating Revenue (X) | 0.25 |
| Price / BV (X) | 0.43 |
| Price / Net Operating Revenue (X) | 0.25 |
| EarningsYield | -0.32 |
After reviewing the key financial ratios for Caprihans India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is -46.26. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is -46.26. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is -13.13. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 295.46. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 295.46. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 514.03. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 35.54. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 6.13. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is -53.82. This value is below the healthy minimum of 0. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -42.53. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -42.53. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 6.91. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is -10.47. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is -8.27. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -8.27. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is -14.39. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is -4.95. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 1.08. This value exceeds the healthy maximum of 1. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.58. This value exceeds the healthy maximum of 1. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 848.61. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 16.70. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is -0.32. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Caprihans India Ltd:
- Net Profit Margin: -8.27%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.96% (Industry Average ROCE: 10.4%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -14.39% (Industry Average ROE: 10.62%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.42
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 51.35)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.58
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -8.27%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Pipes & Fittings | 1028 Shiroli, Rajgurunagar, Pune Maharashtra 410505 | cil@caprihansindia.com www.caprihansindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Ankita J Kariya | Chairperson & Managing Director |
| Mr. Nitin K Joshi | Ind. Non-Executive Director |
| Mr. Siddharth S Shetye | Ind. Non-Executive Director |
| Mr. Sudhir Pendse | Ind. Non-Executive Director |
| Mr. Somenath Mukherjee | Executive Director |
| Mr. Avinash Joshi | Ind. Non-Executive Director |
| Mr. Kavaseri R Viswanathan | Addnl.Non Exe.Independent Director |
| Mr. Pramod Toshniwal | Additional Non Exe.Non Ind.Director |